1
|
Nelson GM, Carswell GK, Swartz CD, Recio L, Yauk CL, Chorley BN. Early microRNA responses in rodent liver mediated by furan exposure establish dose thresholds for later adverse outcomes. Toxicol Lett 2023; 384:105-114. [PMID: 37517673 PMCID: PMC10530563 DOI: 10.1016/j.toxlet.2023.07.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2023] [Accepted: 07/27/2023] [Indexed: 08/01/2023]
Abstract
To reduce reliance on long-term in vivo studies, short-term data linking early molecular-based measurements to later adverse health effects is needed. Although transcriptional-based benchmark dose (BMDT) modeling has been used to estimate potencies and stratify chemicals based on potential to induce later-life effects, dose-responsive epigenetic alterations have not been routinely considered. Here, we evaluated the utility of microRNA (miRNA) profiling in mouse liver and blood, as well as in mouse primary hepatocytes in vitro, to indicate mechanisms of liver perturbation due to short-term exposure of the known rodent liver hepatotoxicant and carcinogen, furan. Benchmark dose modeling of miRNA measurements (BMDmiR) were compared to the referent transcriptional (BMDT) and apical (BMDA) estimates. These analyses indicate a robust dose response for 34 miRNAs to furan and involvement of p53-linked pathways in furan-mediated hepatotoxicity, supporting mRNA and apical measurements. Liver-sourced miRNAs were also altered in the blood and primary hepatocytes. Overall, these results indicate mechanistic involvement of miRNA in furan carcinogenicity and provide evidence of their potential utility as accessible biomarkers of exposure and disease.
Collapse
Affiliation(s)
- Gail M Nelson
- US Environmental Protection Agency, Research Triangle Park, NC 27709, USA
| | - Gleta K Carswell
- US Environmental Protection Agency, Research Triangle Park, NC 27709, USA
| | - Carol D Swartz
- Inotiv Co., 601 Keystone Park Drive, Suite 200, Morrisville, NC 27560, USA
| | - Leslie Recio
- ScitoVation, 100 Capitola Drive Suite 106, Durham, NC 27713, USA
| | - Carole L Yauk
- Dept. Of Biology, University of Ottawa, Ottawa, Ontario K1N 6N5, Canada
| | - Brian N Chorley
- US Environmental Protection Agency, Research Triangle Park, NC 27709, USA.
| |
Collapse
|
2
|
Cave MC, Pinkston CM, Rai SN, Wahlang B, Pavuk M, Head KZ, Carswell GK, Nelson GM, Klinge CM, Bell DA, Birnbaum LS, Chorley BN. Circulating MicroRNAs, Polychlorinated Biphenyls, and Environmental Liver Disease in the Anniston Community Health Survey. Environ Health Perspect 2022; 130:17003. [PMID: 34989596 PMCID: PMC8734566 DOI: 10.1289/ehp9467] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/09/2021] [Revised: 11/05/2021] [Accepted: 11/10/2021] [Indexed: 05/19/2023]
Abstract
BACKGROUND Polychlorinated biphenyl (PCB) exposures have been associated with liver injury in human cohorts, and steatohepatitis with liver necrosis in model systems. MicroRNAs (miRs) maintain cellular homeostasis and may regulate the response to environmental stress. OBJECTIVES We tested the hypothesis that specific miRs are associated with liver disease and PCB exposures in a residential cohort. METHODS Sixty-eight targeted hepatotoxicity miRs were measured in archived serum from 734 PCB-exposed participants in the cross-sectional Anniston Community Health Survey. Necrotic and other liver disease categories were defined by serum keratin 18 (K18) biomarkers. Associations were determined between exposure biomarkers (35 ortho-substituted PCB congeners) and disease biomarkers (highly expressed miRs or previously measured cytokines), and Ingenuity Pathway Analysis was performed. RESULTS The necrotic liver disease category was associated with four up-regulated miRs (miR-99a-5p, miR-122-5p, miR-192-5p, and miR-320a) and five down-regulated miRs (let-7d-5p, miR-17-5p, miR-24-3p, miR-197-3p, and miR-221-3p). Twenty-two miRs were associated with the other liver disease category or with K18 measurements. Eleven miRs were associated with 24 PCBs, most commonly congeners with anti-estrogenic activities. Most of the exposure-associated miRs were associated with at least one serum hepatocyte death, pro-inflammatory cytokine or insulin resistance bioarker, or with both. Within each biomarker category, associations were strongest for the liver-specific miR-122-5p. Pathways of liver toxicity that were identified included inflammation/hepatitis, hyperplasia/hyperproliferation, cirrhosis, and hepatocellular carcinoma. Tumor protein p53 and tumor necrosis factor α were well integrated within the top identified networks. DISCUSSION These results support the human hepatotoxicity of environmental PCB exposures while elucidating potential modes of PCB action. The MiR-derived liquid liver biopsy represents a promising new technique for environmental hepatology cohort studies. https://doi.org/10.1289/EHP9467.
Collapse
Affiliation(s)
- Matthew C. Cave
- Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, School of Medicine, University of Louisville, Louisville, Kentucky, USA
- Department of Pharmacology & Toxicology, School of Medicine, University of Louisville, Louisville, Kentucky, USA
- Department of Biochemistry and Molecular Genetics, University of Louisville School of Medicine, Louisville, Kentucky, USA
- Hepatobiology and Toxicology Center, University of Louisville, Louisville, Kentucky, USA
- Superfund Research Center, University of Louisville, Louisville, Kentucky, USA
- Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, Kentucky, USA
- Robley Rex Veterans Affairs Medical Center, Louisville, Kentucky, USA
- Liver Transplant Program at UofL Health–Jewish Hospital Trager Transplant Center, Louisville, Kentucky, USA
- University of Louisville Alcohol Research Center, Louisville, Kentucky, USA
| | - Christina M. Pinkston
- Hepatobiology and Toxicology Center, University of Louisville, Louisville, Kentucky, USA
- Department of Bioinformatics and Biostatistics, University of Louisville School of Public Health and Information Sciences, Louisville, Kentucky, USA
- Biostatistics and Bioinformatics Facility, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA
| | - Shesh N. Rai
- Hepatobiology and Toxicology Center, University of Louisville, Louisville, Kentucky, USA
- Superfund Research Center, University of Louisville, Louisville, Kentucky, USA
- Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, Kentucky, USA
- University of Louisville Alcohol Research Center, Louisville, Kentucky, USA
- Department of Bioinformatics and Biostatistics, University of Louisville School of Public Health and Information Sciences, Louisville, Kentucky, USA
- Biostatistics and Bioinformatics Facility, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA
| | - Banrida Wahlang
- Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, School of Medicine, University of Louisville, Louisville, Kentucky, USA
- Superfund Research Center, University of Louisville, Louisville, Kentucky, USA
| | - Marian Pavuk
- Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Kimberly Z. Head
- Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, School of Medicine, University of Louisville, Louisville, Kentucky, USA
- Hepatobiology and Toxicology Center, University of Louisville, Louisville, Kentucky, USA
| | - Gleta K. Carswell
- United States Environmental Protection Agency, Research Triangle Park, North Carolina, USA
| | - Gail M. Nelson
- United States Environmental Protection Agency, Research Triangle Park, North Carolina, USA
| | - Carolyn M. Klinge
- Department of Biochemistry and Molecular Genetics, University of Louisville School of Medicine, Louisville, Kentucky, USA
| | - Douglas A. Bell
- National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA
| | - Linda S. Birnbaum
- National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA
| | - Brian N. Chorley
- United States Environmental Protection Agency, Research Triangle Park, North Carolina, USA
| |
Collapse
|
3
|
Chorley BN, Ellinger-Ziegelbauer H, Tackett M, Simutis FJ, Harrill AH, McDuffie J, Atabakhsh E, Nassirpour R, Whiteley LO, Léonard JF, Carswell GK, Harpur E, Chen CL, Gautier JC. Urinary miRNA Biomarkers of Drug-Induced Kidney Injury and Their Site Specificity Within the Nephron. Toxicol Sci 2021; 180:1-16. [PMID: 33367795 PMCID: PMC7916737 DOI: 10.1093/toxsci/kfaa181] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
Drug-induced kidney injury (DIKI) is a major concern in both drug development and clinical practice. There is an unmet need for biomarkers of glomerular damage and more distal renal injury in the loop of Henle and the collecting duct (CD). A cross-laboratory program to identify and characterize urinary microRNA (miRNA) patterns reflecting tissue- or pathology-specific DIKI was conducted. The overall goal was to propose miRNA biomarker candidates for DIKI that could supplement information provided by protein kidney biomarkers in urine. Rats were treated with nephrotoxicants causing injury to distinct nephron segments: the glomerulus, proximal tubule, thick ascending limb (TAL) of the loop of Henle and CD. Meta-analysis identified miR-192-5p as a potential proximal tubule-specific urinary miRNA candidate. This result was supported by data obtained in laser capture microdissection nephron segments showing that miR-192-5p expression was enriched in the proximal tubule. Discriminative miRNAs including miR-221-3p and -222-3p were increased in urine from rats treated with TAL versus proximal tubule toxicants in accordance with their expression localization in the kidney. Urinary miR-210-3p increased up to 40-fold upon treatment with TAL toxicants and was also enriched in laser capture microdissection samples containing TAL and/or CD versus proximal tubule. miR-23a-3p was enriched in the glomerulus and was increased in urine from rats treated with doxorubicin, a glomerular toxicant, but not with toxicants affecting other nephron segments. Taken together these results suggest that urinary miRNA panels sourced from specific nephron regions may be useful to discriminate the pathology of toxicant-induced lesions in the kidney, thereby contributing to DIKI biomarker development needs for industry, clinical, and regulatory use.
Collapse
Affiliation(s)
- Brian N Chorley
- U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27709, USA
| | | | | | - Frank J Simutis
- Bristol-Myers Squibb Company, New Brunswick, New Jersey 08901, USA
| | - Alison H Harrill
- National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA
| | - James McDuffie
- Janssen Research & Development, LLC, San Diego, California 92121, USA
| | | | - Rounak Nassirpour
- Pfizer Drug Safety Research and Development, Cambridge, Massachusetts 02139, USA
| | - Laurence O Whiteley
- Pfizer Drug Safety Research and Development, Cambridge, Massachusetts 02139, USA
| | | | - Gleta K Carswell
- U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27709, USA
| | - Ernie Harpur
- Newcastle University, Newcastle upon Tyne NE1 7RU, UK
| | - Connie L Chen
- Health and Environmental Sciences Institute, Washington, District of Columbia 20005, USA
| | | |
Collapse
|
4
|
Miller CN, Dye JA, Henriquez AR, Stewart EJ, Lavrich KS, Carswell GK, Ren H, Freeborn DL, Snow SJ, Schladweiler MC, Richards JH, Kodavanti PRS, Fisher A, Chorley BN, Kodavanti UP. Ozone-induced fetal growth restriction in rats is associated with sexually dimorphic placental and fetal metabolic adaptation. Mol Metab 2020; 42:101094. [PMID: 33031959 PMCID: PMC7588867 DOI: 10.1016/j.molmet.2020.101094] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/29/2020] [Revised: 09/16/2020] [Accepted: 09/28/2020] [Indexed: 12/14/2022] Open
Abstract
Objective The importance of the placenta in mediating the pre- and post-natal consequences of fetal growth restriction has been increasingly recognized. However, the influence of placental sexual dimorphism on driving these outcomes has received little attention. The purpose of this study was to characterize how sex contributes to the relationship between placental metabolism and fetal programming utilizing a novel rodent model of growth restriction. Methods Fetal growth restriction was induced by maternal inhalation of 0.8 ppm ozone (4 h/day) during implantation receptivity (gestation days [GDs] 5 and 6) in Long-Evans rats. Control rats were exposed to filtered air. At GD 21, placental and fetal tissues were obtained for metabolic and genomic assessments. Results Growth-restricted male placentae exhibited increased mitochondrial biogenesis, increased oxygen consumption, and reduced nutrient storage. Male growth-restricted fetuses also had evidence of reduced adiposity and downregulation of hepatic metabolic signaling. In contrast, placentae from growth-restricted females had elevated markers of autophagy accompanied by an observed protection against hepatic metabolic perturbations. Despite this, growth restriction in females induced a greater number of hypothalamic gene and pathway alterations compared to growth-restricted males. Conclusions Increases in mitochondrial metabolism in growth-restricted male placentae likely initiates a sequela of adaptations that promote poor nutrient availability and adiposity. Divergently, the female placenta expresses protective mechanisms that may serve to increase nutrient availability to support fetal metabolic development. Collectively, this work emphasizes the importance of sex in mediating alterations in placental metabolism and fetal programming. Peri-implantation exposure to the gaseous air pollutant ozone impairs fetal growth. Ozone-induced, growth-restricted male placentae have increased mitochondrial biogenesis and oxidative consumption. Female growth-restricted placentae show increased inflammatory and autophagy-like responses. Placental metabolic adaptations to growth restriction were associated with sexually dimorphic perturbations in fetal tissues.
Collapse
Affiliation(s)
- Colette N Miller
- Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, 109 T.W. Alexander Dr., Mail Code: B105-02, Research Triangle Park, NC, 27711, USA; Oak Ridge Institute for Science and Education Research Participation Program, US Environmental Protection Agency, 109 T.W. Alexander Dr., Mail Code: B105-02, Research Triangle Park, NC, 27711, USA.
| | - Janice A Dye
- Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, 109 T.W. Alexander Dr., Mail Code: B105-02, Research Triangle Park, NC, 27711, USA
| | - Andres R Henriquez
- Oak Ridge Institute for Science and Education Research Participation Program, US Environmental Protection Agency, 109 T.W. Alexander Dr., Mail Code: B105-02, Research Triangle Park, NC, 27711, USA
| | - Erica J Stewart
- Oak Ridge Institute for Science and Education Research Participation Program, US Environmental Protection Agency, 109 T.W. Alexander Dr., Mail Code: B105-02, Research Triangle Park, NC, 27711, USA
| | - Katelyn S Lavrich
- Division of the National Toxicology Program, National Institute of Environmental Health Sciences, 530 Davis Dr., Keystone Building, Durham, NC, 27713, USA
| | - Gleta K Carswell
- Biomolecular and Computational Toxicology Division, Center for Computational Toxicology and Exposure, Office of Research and Development, US Environmental Protection Agency, 109 T.W. Alexander Dr., Mail Code: B105-02, Research Triangle Park, NC, 27711, USA
| | - Hongzu Ren
- Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, 109 T.W. Alexander Dr., Mail Code: B105-02, Research Triangle Park, NC, 27711, USA
| | - Danielle L Freeborn
- Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, 109 T.W. Alexander Dr., Mail Code: B105-02, Research Triangle Park, NC, 27711, USA
| | - Samantha J Snow
- Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, 109 T.W. Alexander Dr., Mail Code: B105-02, Research Triangle Park, NC, 27711, USA
| | - Mette C Schladweiler
- Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, 109 T.W. Alexander Dr., Mail Code: B105-02, Research Triangle Park, NC, 27711, USA
| | - Judy H Richards
- Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, 109 T.W. Alexander Dr., Mail Code: B105-02, Research Triangle Park, NC, 27711, USA
| | - Prasada R S Kodavanti
- Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, 109 T.W. Alexander Dr., Mail Code: B105-02, Research Triangle Park, NC, 27711, USA
| | - Anna Fisher
- Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, 109 T.W. Alexander Dr., Mail Code: B105-02, Research Triangle Park, NC, 27711, USA
| | - Brian N Chorley
- Biomolecular and Computational Toxicology Division, Center for Computational Toxicology and Exposure, Office of Research and Development, US Environmental Protection Agency, 109 T.W. Alexander Dr., Mail Code: B105-02, Research Triangle Park, NC, 27711, USA
| | - Urmila P Kodavanti
- Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, 109 T.W. Alexander Dr., Mail Code: B105-02, Research Triangle Park, NC, 27711, USA
| |
Collapse
|
5
|
Lake AD, Wood CE, Bhat VS, Chorley BN, Carswell GK, Sey YM, Kenyon EM, Padnos B, Moore TM, Tennant AH, Schmid JE, George BJ, Ross DG, Hughes MF, Corton JC, Simmons JE, McQueen CA, Hester SD. Dose and Effect Thresholds for Early Key Events in a PPARα-Mediated Mode of Action. Toxicol Sci 2015; 149:312-25. [PMID: 26519955 DOI: 10.1093/toxsci/kfv236] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Current strategies for predicting adverse health outcomes of environmental chemicals are centered on early key events in toxicity pathways. However, quantitative relationships between early molecular changes in a given pathway and later health effects are often poorly defined. The goal of this study was to evaluate short-term key event indicators using qualitative and quantitative methods in an established pathway of mouse liver tumorigenesis mediated by peroxisome proliferator-activated receptor alpha (PPARα). Male B6C3F1 mice were exposed for 7 days to di (2-ethylhexyl) phthalate (DEHP), di-n-octyl phthalate (DNOP), and n-butyl benzyl phthalate (BBP), which vary in PPARα activity and liver tumorigenicity. Each phthalate increased expression of select PPARα target genes at 7 days, while only DEHP significantly increased liver cell proliferation labeling index (LI). Transcriptional benchmark dose (BMDT) estimates for dose-related genomic markers stratified phthalates according to hypothetical tumorigenic potencies, unlike BMDs for non-genomic endpoints (relative liver weights or proliferation). The 7-day BMDT values for Acot1 as a surrogate measure for PPARα activation were 29, 370, and 676 mg/kg/day for DEHP, DNOP, and BBP, respectively, distinguishing DEHP (liver tumor BMD of 35 mg/kg/day) from non-tumorigenic DNOP and BBP. Effect thresholds were generated using linear regression of DEHP effects at 7 days and 2-year tumor incidence values to anchor early response molecular indicators and a later phenotypic outcome. Thresholds varied widely by marker, from 2-fold (Pdk4 and proliferation LI) to 30-fold (Acot1) induction to reach hypothetical tumorigenic expression levels. These findings highlight key issues in defining thresholds for biological adversity based on molecular changes.
Collapse
Affiliation(s)
- April D Lake
- *Curriculum in Toxicology, University of North Carolina, Chapel Hill, North Carolina 27599; Oak Ridge Institute for Science and Education (ORISE) participant at the National Health and Environmental Effects Research Laboratory (NHEERL), Office of Research and Development (ORD), U.S. Environmental Protection Agency (U.S. EPA), Research Triangle Park, North Carolina 27711; Integrated Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park, North Carolina 27711
| | - Charles E Wood
- Integrated Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park, North Carolina 27711
| | | | - Brian N Chorley
- Integrated Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park, North Carolina 27711
| | - Gleta K Carswell
- Integrated Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park, North Carolina 27711
| | - Yusupha M Sey
- Integrated Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park, North Carolina 27711
| | - Elaina M Kenyon
- Integrated Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park, North Carolina 27711
| | - Beth Padnos
- Integrated Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park, North Carolina 27711
| | - Tanya M Moore
- Integrated Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park, North Carolina 27711
| | - Alan H Tennant
- Integrated Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park, North Carolina 27711
| | | | - Barbara Jane George
- Office of the Associate Director for Health, NHEERL, ORD, U.S. EPA, Research Triangle Park, North Carolina 27711
| | - David G Ross
- Integrated Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park, North Carolina 27711
| | - Michael F Hughes
- Integrated Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park, North Carolina 27711
| | - J Christopher Corton
- Integrated Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park, North Carolina 27711
| | - Jane Ellen Simmons
- Integrated Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park, North Carolina 27711
| | - Charlene A McQueen
- Integrated Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park, North Carolina 27711
| | - Susan D Hester
- Integrated Systems Toxicology Division, NHEERL, ORD, U.S. EPA, Research Triangle Park, North Carolina 27711;
| |
Collapse
|
6
|
Meadows KL, Andrews DMK, Xu Z, Carswell GK, Laughlin SK, Baird DD, Taylor JA. Genome-wide analysis of loss of heterozygosity and copy number amplification in uterine leiomyomas using the 100K single nucleotide polymorphism array. Exp Mol Pathol 2011; 91:434-9. [PMID: 21497600 DOI: 10.1016/j.yexmp.2011.03.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2011] [Accepted: 03/29/2011] [Indexed: 10/18/2022]
Abstract
PURPOSE Uterine leiomyomas (fibroids) are benign smooth muscle tumors commonly found among reproductive-aged women. Though benign, these tumors are the leading indication for hysterectomies in the United States and cause significant morbidity. Despite the importance of this tumor in women's health, relatively little is known about the molecular etiology. METHODS In this study, we used the Affymetrix 100K single nucleotide polymorphism (SNP) chip to assess whether the pattern and frequency of genome-wide loss of heterozygosity (LOH) and copy number amplifications is associated with clinical heterogeneity. RESULTS Thirty-seven tumors with varying sizes and histology from eleven patients were analyzed. LOH was observed in 4/37 tumors (10.8%) and significantly associated with large-sized tumors (p<0.0014). Two tumors revealed hemizygosity on chromosome 7q, a region that has been consistently reported to have LOH. Additionally, we detected one novel region of LOH, 16p13.11 in one tumor (2.7%). Copy number amplifications were observed on all chromosomes; however, most were low-level amplifications and only detected in a single tumor. One region of amplification at 3p26.3 was detected in four tumors. CONCLUSIONS Despite the use of a high-density SNP platform, our results suggest that genome-wide LOH and copy number amplifications are infrequent events and generally do not determine clinical and histologic characteristics of this disease.
Collapse
Affiliation(s)
- Kellen L Meadows
- Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA
| | | | | | | | | | | | | |
Collapse
|
7
|
Carswell GK, Johnson CM, Shillito RD, Harms CT. O-acetyl-salicylic acid promotes colony formation from protoplasts of an elite maize inbred. Plant Cell Rep 1989; 8:282-4. [PMID: 24233226 DOI: 10.1007/bf00274130] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/31/1989] [Revised: 06/09/1989] [Indexed: 05/10/2023]
Abstract
The salicylic acid derivative acetylsalicylic acid (ASA) was found to promote colony formation from protoplasts isolated from embryogenic suspension cultures of an elite maize inbred line. The drug was most effective at concentrations of 30-100 mg/l, and increases of more than 20-fold in the number of colonies recovered from protoplasts were obtained. The rate of growth of protoplast-derived cell colonies was not affected.
Collapse
Affiliation(s)
- G K Carswell
- Agricultural Biotechnology Research, Ciba-Geigy Corporation, P.O. Box 12257, NC 27709, Research Triangle Park, North Carolina, USA
| | | | | | | |
Collapse
|